The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Enzyme-Replacement Therapy in Life-Threatening Hypophosphatasia
Open accessAbstract
BACKGROUND: Hypophosphatasia results from mutations in the gene for the tissue-nonspecific isozyme of alkaline phosphatase (TNSALP). Inorganic pyrophosphate accumulates extracellularly, leading to rickets or osteomalacia. Severely affected babies often die from respiratory insufficiency due to progressive chest deformity or have persistent bone disease. There is no approved medical therapy. ENB-0040 is a bone-targeted, recombinant human TNSALP that prevents the manifestations of hypophosphatasia in Tnsalp knockout mice. METHODS: We enrolled infants and young children with life-threatening or debilitating perinatal or infantile hypophosphatasia in a multinational, open-label study of treatment with ENB-0040. The primary objective was the healing of rickets, as assessed by means of radiographic scales. Motor and cognitive development, respiratory function, and safety were evaluated, as well as the pharmacokinetics and pharmacodynamics of ENB-0040. RESULTS: Of the 11 patients recruited, 10 completed 6 months of therapy; 9 completed 1 year. Healing of rickets at 6 months in 9 patients was accompanied by improvement in developmental milestones and pulmonary function. Elevated plasma levels of the TNSALP substrates inorganic pyrophosphate and pyridoxal 5'-phosphate diminished. Increases in serum parathyroid hormone accompanied skeletal healing, often necessitating dietary calcium supplementation. There was no evidence of hypocalcemia, ectopic calcification, or definite drug-related serious adverse events. Low titers of anti-ENB-0040 antibodies developed in four patients, with no evident clinical, biochemical, or autoimmune abnormalities at 48 weeks of treatment. CONCLUSIONS: ENB-0040, an enzyme-replacement therapy, was associated with improved findings on skeletal radiographs and improved pulmonary and physical function in infants and young children with life-threatening hypophosphatasia. (Funded by Enobia Pharma and Shriners Hospitals for Children; ClinicalTrials.gov number, NCT00744042.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Individual Comparisons by Ranking Methods
Wilcoxon, F. (1945) · Biometrics Bulletin · doi:10.2307/3001968 · Cited by 15,354
THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL
CLOPPER, C. J., & PEARSON, E. S. (1934) · Biometrika · doi:10.1093/biomet/26.4.404 · Cited by 5,003
(2020) · Elsevier eBooks · doi:10.1016/c2015-1-01622-2 · Cited by 1,683
Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification
Rutsch, F., Ruf, N., Vaingankar, S., Toliat, M. R., Suk, A., Höhne, W., Schauer, G., Lehmann, M., Roscioli, T., Schnabel, D., et al. (2003) · Nature Genetics · doi:10.1038/ng1221 · Cited by 609
Murshed, M., Harmey, D., Millán, J. L., McKee, M. D., & Karsenty, G. (2005) · Genes & Development · doi:10.1101/gad.1276205 · Cited by 601
Self-citationEffect of Pyrophosphate on Hydroxyapatite and Its Implications in Calcium Homeostasis
FLEISCH, H., RUSSELL, R. G. G., & STRAUMANN, F. (1966) · Nature · doi:10.1038/212901a0 · Cited by 517
Mammalian Alkaline Phosphatases: From Biology to Applications in Medicine and Biotechnology
Millán, J. L. (2006) · doi:10.1002/3527608060 · Cited by 421
Self-citationFedde, K. N., Blair, L., Silverstein, J., Coburn, S. P., Ryan, L. M., Weinstein, R. S., Waymire, K., Narisawa, S., Millán, J. L., Macgregor, G. R., et al. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.12.2015 · Cited by 405
Self-citationFraser, D. (1957) · The American Journal of Medicine · doi:10.1016/0002-9343(57)90124-9 · Cited by 389
Weiss, M. J., Cole, D. E., Ray, K., Whyte, M. P., Lafferty, M. A., Mulivor, R. A., & Harris, H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7666 · Cited by 340
Self-citationEnzyme Replacement Therapy for Murine Hypophosphatasia
Millán, J. L., Narisawa, S., Lemire, I., Loisel, T. P., Boileau, G., Leonard, P., Gramatikova, S., Terkeltaub, R., Camacho, N. P., McKee, M. D., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.071213 · Cited by 262
Self-citationEXCRETION OF INORGANIC PYROPHOSPHATE IN HYPOPHOSPHATASIA
RUSSELL, R. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91422-4 · Cited by 178
Adult Hypophosphatasia Treated with Teriparatide
Whyte, M. P., Mumm, S., & Deal, C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1902 · Cited by 165
Self-citationWenkert, D., McAlister, W. H., Coburn, S. P., Zerega, J., Ryan, L. M., Ericson, K. L., Hersh, J. H., Mumm, S. R., & Whyte, M. P. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.454 · Cited by 144
Self-citationCementum and Dentin in Hypophosphatasia
van den Bos, T., Handoko, G., Niehof, A., Ryan, L. M., Coburn, S. P., Whyte, M. P., & Beertsen, W. (2005) · Journal of Dental Research · doi:10.1177/154405910508401110 · Cited by 141
Self-citationEnzyme Replacement Therapy Prevents Dental Defects in a Model of Hypophosphatasia
McKee, M. D., Nakano, Y., Masica, D. L., Gray, J. J., Lemire, I., Heft, R., Whyte, M. P., Crine, P., & Millán, J. L. (2011) · Journal of Dental Research · doi:10.1177/0022034510393517 · Cited by 128
Self-citationWhyte, M. P., Mahuren, J. D., Fedde, K. N., Cole, F. S., McCabe, E. R. B., & Coburn, S. P. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113440 · Cited by 109
Self-citationWhyte, M. P., Valdes, R., Ryan, L. M., & McAlister, W. H. (1982) · The Journal of Pediatrics · doi:10.1016/s0022-3476(82)80061-9 · Cited by 81
Self-citationWhyte, M. P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00080-x · Cited by 73
Self-citationDose response of bone-targeted enzyme replacement for murine hypophosphatasia
Yadav, M. C., Lemire, I., Léonard, P., Boileau, G., Blond, L., Béliveau, M., Cory, E., Sah, R. L., Whyte, M. P., Crine, P., et al. (2011) · Bone · doi:10.1016/j.bone.2011.03.770 · Cited by 52
Self-citation
Cited by
Hypophosphatasia — aetiology, nosology, pathogenesis, diagnosis and treatment
Whyte, M. P. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.14 · Cited by 511
Self-citationAlkaline Phosphatase and Hypophosphatasia
Millán, J. L., & Whyte, M. P. (2016) · Calcified Tissue International · doi:10.1007/s00223-015-0079-1 · Cited by 397
Self-citationBone Turnover Markers: Basic Biology to Clinical Applications
Schini, M., Vilaca, T., Gossiel, F., Salam, S., & Eastell, R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac031 · Cited by 387
Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD
Haarhaus, M., Brandenburg, V., Kalantar-Zadeh, K., Stenvinkel, P., & Magnusson, P. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.60 · Cited by 316
Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia
Whyte, M. P., Rockman-Greenberg, C., Ozono, K., Riese, R., Moseley, S., Melian, A., Thompson, D. D., Bishop, N., & Hofmann, C. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3462 · Cited by 266
Self-citation
Metadata
- Authors
- Whyte, M. P., Greenberg, C. R., Salman, N. J., Bober, M. B., McAlister, W. H., Wenkert, D., Van Sickle, B. J., Simmons, J. H., Edgar, T. S., Bauer, M. L., Hamdan, M. A., Bishop, N., Lutz, R. E., McGinn, M., Craig, S., Moore, J. N., Taylor, J. W., Cleveland, R. H., Cranley, W. R., Lim, R., Thacher, T. D., Mayhew, J. E., Downs, M., Millán, J. L., Skrinar, A. M., Crine, P., & Landy, H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-03-08
- Volume
- 366
- Issue
- 10
- Pages
- 904-913
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2141225628
- Cited by
- 568
- References
- 20
- FWCI
- 28.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.